Evaluation and Management of Elevated Alkaline Phosphatase (ALP)

Overview

• Elevated ALP most commonly signals cholestatic liver disease, bone disease, or an underlying malignancy; the precise etiology is clarified by concurrent γ‑glutamyl transpeptidase (GGT) measurement and targeted imaging. – American College of Radiology 1

Tissue Sources and Physiologic Elevations

• Hepatobiliary ALP is produced by the canalicular membrane of hepatocytes and the biliary epithelium. – American College of Radiology 1
• Bone ALP originates from osteoblasts and rises during periods of active bone growth and remodeling. – American College of Radiology 1
• Minor contributions come from intestines, kidneys, white‑blood cells, and placenta. – American College of Radiology 1
• Physiologic ALP elevation occurs in childhood and adolescence due to rapid bone growth. – American College of Radiology 1
• Pregnancy raises ALP levels via placental production. – American College of Radiology 1
• Post‑menopausal women may exhibit higher ALP from osteoporosis‑related bone turnover. – Alimentary Pharmacology & Therapeutics 3

Hepatobiliary Pathologic Causes

Extra‑hepatic Biliary Obstruction

• Choledocholithiasis is the leading cause of extra‑hepatic biliary obstruction and liver‑origin ALP elevation. – American College of Radiology 1, 2

Chronic Cholestatic Liver Diseases

• Persistent isolated hepatic ALP elevation suggests chronic cholestasis. – American College of Radiology 1
• Primary biliary cholangitis is a recognized chronic cholestatic disorder associated with ALP rise. – American College of Radiology; Alimentary Pharmacology & Therapeutics 1, 3
• Primary sclerosing cholangitis similarly produces chronic ALP elevation. – American College of Radiology; Alimentary Pharmacology & Therapeutics 1, 3
• Partial bile‑duct obstruction can cause isolated ALP elevation. – American College of Radiology 1
• Drug‑induced cholestasis is a frequent iatrogenic cause of elevated hepatic ALP. – American College of Radiology; Alimentary Pharmacology & Therapeutics 1, 3

Infiltrative Liver Diseases

• Sarcoidosis may present with isolated ALP elevation due to hepatic infiltration. – American College of Radiology 1
• Amyloidosis can also produce infiltrative hepatic ALP elevation. – American College of Radiology 1

Nonspecific Hepatic Elevations

• Cirrhosis of any etiology can modestly raise ALP. – Gastroenterology 4
• Chronic and viral hepatitis are associated with mild ALP increases. – Gastroenterology 4
• Congestive heart failure (hepatic congestion) may elevate ALP. – American College of Radiology 1
• Ischemic cholangiopathy is another hepatic condition linked to ALP rise. – American College of Radiology 1

Bone Pathologic Causes

• Paget’s disease of bone is a common skeletal disorder causing marked ALP elevation. – American College of Radiology; Journal of the American College of Radiology 1, 2
• Bony metastases (especially from prostate, breast, or lung cancer) raise ALP and carry prognostic significance. – American College of Radiology; Cancer Treatment Reviews 1, 5
• Healing fractures lead to transient ALP elevation during the reparative phase. – American College of Radiology 1
• Osteomalacia, though rare today, can produce elevated ALP. – Gut 6

Diagnostic Approach

Step 1 – GGT and ALP Isoenzyme Testing

• GGT is present in liver but absent in bone; measuring GGT helps differentiate hepatic from skeletal ALP sources. – American College of Radiology 1, 2
• A concurrent rise in GGT confirms a hepatic origin and indicates cholestasis. – American College of Radiology; Alimentary Pharmacology & Therapeutics 1, 3
• Normal GGT with elevated ALP points toward bone or other non‑hepatic sources. – American College of Radiology 1
• When GGT results are equivocal, ALP isoenzyme fractionation can directly identify the tissue of origin. – Alimentary Pharmacology & Therapeutics 3

Step 2 – Imaging for Hepatobiliary Sources

• Abdominal ultrasound is the first‑line modality to detect biliary obstruction. – American College of Radiology 1, 2
• Magnetic resonance cholangiopancreatography (MRCP) is recommended for persistent ALP elevation after a negative ultrasound. – American College of Radiology 1

Step 3 – Evaluation for Bone Sources

• Bone‑specific ALP (B‑ALP) measurement is elevated in bone metastases and serves as a prognostic marker. – Cancer Treatment Reviews 5
• Bone scintigraphy or cross‑sectional imaging (CT/MRI) should be performed when metastatic bone disease is suspected. – Cancer Treatment Reviews 5

Clinical Pitfalls and Recommendations

• Do not assume all ALP elevations are hepatic; always confirm origin with GGT or isoenzyme testing, especially in post‑menopausal women and patients with known bone disease. – Alimentary Pharmacology & Therapeutics 3
• A thorough medication review is essential because many drugs cause drug‑induced cholestasis. – American College of Radiology; Alimentary Pharmacology & Therapeutics 1, 3